Epinastine

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

HealthyRhinitis, Allergic, Perennial

Phase 1

Epinastine and Pseudoephedrine Fixed Combination Compared to Separate Administration in Healthy Volunteers

CompletedNCT02182531

Boehringer IngelheimHealthy

Start: 1999-08-31Updated: 2014-07-14

Phase 3

Epinastine + Pseudoephedrine SR (Slow Release) Versus Epinastine Alone in Patients With Perennial Allergic Rhinitis

CompletedNCT02182518

Boehringer IngelheimRhinitis, Allergic, Perennial

Start: 2000-05-31Updated: 2014-07-14